Sands Capital Management’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History
Bought
Maintained
Sold
Other funds holding LKFT
RSCM
EAM
Sands Capital Management's LKFT Position: Q4 2020 in Review
Sands Capital Management sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q4 2020, closing a stake of 2,284,744 shares — an estimated $324M sold.
Sands Capital Management first reported a position in LKFT in Q2 2017 and held it in 14 quarters. The position peaked at $547M in Q4 2019. 116 funds tracked by Wall St. Rank hold LKFT as of Q4 2020.
- Sands Capital Management reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q4 2020 after selling out during the quarter.
- Sands Capital Management sold 2,284,744 Lakefront Biotherapeutics American Depositary Shares shares in Q4 2020, an estimated $324M.
- Sands Capital Management first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q2 2017 and held it in 14 quarters.
- Sands Capital Management's Lakefront Biotherapeutics American Depositary Shares position peaked at $547M in Q4 2019.
- 116 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q4 2020.
Based on Sands Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.